mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Recovery from COVID-19, RCGP (updated 4th January 2021)
This 30-minute, updated (4th January 2021) RCGP Learning course summarises what is known so far about sequelae of COVID-19 and reflects on what can be learnt from other causes of severe illness, including previous coronavirus outbreaks, for example Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2021 Category: Consumer Health News Source Type: news

Origin story: what do we know now about where coronavirus came from?
When Chinese scientists alerted colleagues to a new virus last December, suspicion fell on a Wuhan market. What have health officials learned since then?Show your support for rigorous, independent Guardian journalismCoronavirus – latest updatesSee all our coronavirus coverageMaria van Kerkhove was staying with her sister in the US for the Christmas holidays, but checking her emails. As always. Every day there are signals of potential trouble, said the World Health Organization virologist who was to become a household name and face within weeks.“There’s always something that happens at Christmas time. Ther...
Source: Guardian Unlimited Science - December 12, 2020 Category: Science Authors: Sarah Boseley Tags: Coronavirus Medical research Infectious diseases Biology World news Health China Asia Pacific World Health Organization Microbiology Science Society Long Covid Animals Source Type: news

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a grave threat to public health and the global economy. SARS-CoV-2 is closely related to the more lethal but less transmissible coronaviruses SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV). Here, we have carried out comparative viral-human protein-protein interaction and viral protein localization analyses for all three viruses. Subsequent functional genetic screening identified host factors that functionally impinge on coronavirus proliferation, including Tom70, a mitochondrial chaperone protein that i...
Source: ScienceNOW - December 3, 2020 Category: Science Authors: Gordon, D. E., Hiatt, J., Bouhaddou, M., Rezelj, V. V., Ulferts, S., Braberg, H., Jureka, A. S., Obernier, K., Guo, J. Z., Batra, J., Kaake, R. M., Weckstein, A. R., Owens, T. W., Gupta, M., Pourmal, S., Titus, E. W., Cakir, M., Soucheray, M., McGregor, M Tags: Engineering, Microbiology, Online Only r-articles Source Type: news

The long game: the race for a vaccine against all coronaviruses
There is hope that Covid-19 immunisation might soon be a reality, but some scientists are aiming for a broader solutionCoronavirus – latest updatesSee all our coronavirus coverageHopes have been raised worldwide this week that a Covid-19 vaccine is getting closer, after one version was shown to be 90% effective in reducing disease symptoms, but a handful of scientists are working on an ambitious plan for a different sort of vaccine.Their project, which is fraught with technical and financial challenges, is to find a vaccine that could protect against not just Covid, but other viruses in the same family that cause Sar...
Source: Guardian Unlimited Science - November 13, 2020 Category: Science Authors: Natalie Grover Tags: Coronavirus Infectious diseases Medical research Microbiology Science World news Vaccines and immunisation Health Society Source Type: news

The Covid-carrying Danish mink are a warning sign – but is anyone heeding it? | Matthew Baylis
Sars, Mers, now this: we must think hard about how we farm animals that are known hosts of human coronavirusesTwo decades ago, aseminal study from the University of Edinburgh compiled a list of all known human infectious diseases. It found a total of 1,415 different human pathogens, and claimed that 61% were capable of spreading between humans and animals. Today, with the world put on hold by adeadly disease that seems likely to have spread first from bats to humans, we know the dangerous effects of such pathogens all too well.The group of diseases that spread from animals to humans are collectively known as zoonoses. The ...
Source: Guardian Unlimited Science - November 10, 2020 Category: Science Authors: Matthew Baylis Tags: Coronavirus Farming Environment Science Sars Infectious diseases Denmark Europe Source Type: news

The Covid Pandemic: Broadening the Discourse
Thailand’s COVID-19 response an example of resilience and solidarity: a UN Resident Coordinator’s BlogBy Asoka BandarageCOLOMBO, Sri Lanka, Nov 10 2020 (IPS) SARS-CoV-2, the corona virus that causes COVID-19, has been spreading exponentially across the world over the last ten or so months. As of November 6th, according to the Center for Systems Science at Johns Hopkins University, there have been 49,195,581 cases of COVID-19, including 1,241,031 deaths. More than a third of the global population has been placed on lockdown. The global economy is experiencing the deepest global recession since World War 2 and m...
Source: IPS Inter Press Service - Health - November 10, 2020 Category: International Medicine & Public Health Authors: Asoka Bandarage Tags: Featured Global Headlines Health Human Rights Humanitarian Emergencies Peace TerraViva United Nations Source Type: news

Supporting resilience and mental well-being in frontline healthcare professionals during and after a pandemic
This study was carried out immediately after the Ebola outbreak, and investigated whether staff who were training to give other people (such as patients and their family members)'psychological first aid'felt less ‘burnt out’. The authors had some concerns about the results that this study reported and about some of its methods. This means that confidence in the evidence is very low and the authors cannot say whether the intervention helped or not.Objective 2: all 16 studies provided some evidence about barriers and facilitators to implement interventions. The author team found 17 main findings from these studie...
Source: Cochrane News and Events - November 5, 2020 Category: Information Technology Authors: Katie Abbotts Source Type: news

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a global crisis. Key to SARS-CoV-2 therapeutic development is unraveling the mechanisms that drive high infectivity, broad tissue tropism, and severe pathology. Our 2.85-angstrom cryo–electron microscopy structure of SARS-CoV-2 spike (S) glycoprotein reveals that the receptor binding domains tightly bind the essential free fatty acid linoleic acid (LA) in three composite binding pockets. A similar pocket also appears to be present in the highly pathogenic severe acute respiratory syndrome coronaviru...
Source: ScienceNOW - November 5, 2020 Category: Science Authors: Toelzer, C., Gupta, K., Yadav, S. K. N., Borucu, U., Davidson, A. D., Kavanagh Williamson, M., Shoemark, D. K., Garzoni, F., Staufer, O., Milligan, R., Capin, J., Mulholland, A. J., Spatz, J., Fitzgerald, D., Berger, I., Schaffitzel, C. Tags: Biochemistry reports Source Type: news

New COVID-19 related genes — helpful and harmful — found in massive screen
Research by Yale and partner institutions sheds new light on the genetics behind cells ’ susceptibility to infection by SARS-Cov-2 and MERS viruses. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 26, 2020 Category: Universities & Medical Training Source Type: news

New COVID-19 related genes -- helpful and harmful -- found in massive screen
(Yale University) Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus. The pro-viral and anti-viral role of these genes will help guide scientists in development of new therapies to combat COVID-19, the researchers say. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 26, 2020 Category: International Medicine & Public Health Source Type: news

COMMENTARY: The Sinatra Doctrine Confronts a Global Consensus
A photo-collage. Credit: Peter Costantini.By Peter CostantiniSEATTLE, Oct 23 2020 (IPS) By late September, the COVID-19 pandemic in the United States had claimed 200,000 lives. That’s equivalent to a slightly higher toll than the 418,500 United States deaths in World War II, adjusted for relative population and duration. [See note below.] With four percent of the world’s population, the U.S. has suffered 20 percent of global COVID-19 deaths. Tragically, most of these deaths need never have happened. They were caused primarily by the public-health equivalent of friendly fire: massive malpractice and deception by...
Source: IPS Inter Press Service - Health - October 23, 2020 Category: International Medicine & Public Health Authors: Peter Costantini Tags: Global Geopolitics Global Governance Headlines Health TerraViva United Nations Source Type: news

What Developing Countries Can Teach Us About How To Respond To a Pandemic
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post What Developing Countries Can Teach Us About How To Respond To a Pandemic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 16, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health TerraViva United Nations Source Type: news

Scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses
In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the Institut Pasteur and CNRS, studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 and MERS-CoV in order to identify commonly hijacked cellular pathways and detect promising targets for broad coronavirus inhibition. In addition, (Source: World Pharma News)
Source: World Pharma News - October 16, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

The mental health impact of pandemics for front line health care staff
(University of East Anglia) New research shows the impact that pandemics have on the mental health of front-line health care staff.Researchers investigated how treating patients in past pandemics such as SARS and MERS affected the mental health of front-line staff.They found that over a third experienced anxiety or depression, almost a quarter experienced PTSD.The team hope that their work will help highlight the impact that the Covid-19 pandemic could be having on the mental health of doctors and nurses worldwide. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 16, 2020 Category: Infectious Diseases Source Type: news

Aetion statement on UCSF-led study to inform drug development for COVID-19, future pandemics
(Aetion) Aetion co-authored a study published today inScience, which examined lethal coronaviruses SARS-CoV-2, SARS-CoV-1, and MERS-CoV to identify molecular characteristics of potential treatments. The study, which was led by the Quantitative Biosciences Institute at UCSF and involved nearly 200 researchers from leading institutions, applied a novel approach to evaluate molecular hypotheses by analyzing real-world data from COVID-19 patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news

Global study identifies common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses
(Georgia State University) There are common vulnerabilities among three lethal coronaviruses, SARS-CoV-2, SARS-CoV-1 and MERS-CoV, such as frequently hijacked cellular pathways, that could lead to promising targets for broad coronavirus inhibition, according to a study by an international research team that includes scientists from the Institute for Biomedical Sciences at Georgia State University. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news

Team of international scientists identify common vulnerabilities across coronaviruses
(University of California - San Francisco) In a study published online inScience, today, an international team of almost 200 researchers from 14 leading institutions in six countries studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 and MERS-CoV in order to identify commonly hijacked cellular pathways and detect promising targets for broad coronavirus inhibition. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news

Repurposing drugs for a pan-coronavirus treatment
(European Molecular Biology Laboratory - European Bioinformatics Institute) The study identifies drug targets common to all three coronaviruses (SARS-CoV-2, SARS-CoV-1, and MERS-CoV) and potential drugs that could be repurposed as COVID-19 treatments. The researchers suggest that repurposed pan-coronavirus therapeutics may offer a rapid treatment response against future emerging coronavirus strains (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 15, 2020 Category: Infectious Diseases Source Type: news

'Brain fog' following COVID-19 recovery may indicate PTSD
(University of California - Los Angeles Health Sciences) A new report suggests that lingering " brain fog " and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), an effect observed in past human coronavirus outbreaks such as SARS and MERS. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 6, 2020 Category: Infectious Diseases Source Type: news

Persistence of SARS-CoV-2 in Aerosol Suspensions Persistence of SARS-CoV-2 in Aerosol Suspensions
How does the aerosol efficiency of SARS-CoV-2 compare with that of SARS-CoV and MERS-CoV?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 28, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

What are the effects of quarantine for close contacts of people with confirmed COVID19?, Cochrane Clinical Answers
Reviewers conducted a rapid review of the evidence on quarantine for close contacts of people with confirmed COVID ‐19 (plus isolation of the infected individual) and identified one observational study conducted in Singapore, along with eight modeling studies based on data collected from China, Singapore, the UK, the cruise ship Diamond Princess, or generic populations. Studies reported that quarantine for clo se contacts decreased the incidence of COVID‐19, mortality, and resource use (such as hospitalization and numbers of doctors and nurses needed in intensive care units). Reviewers rated the certainty of all eviden...
Source: Current Awareness Service for Health (CASH) - September 24, 2020 Category: Consumer Health News Source Type: news

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Media News - September 18, 2020 Category: Pharmaceuticals Source Type: news

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines
Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys ® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can play an important part in characterising a vaccine-induced immune response.1 Specifically, the test targets antibodies which are directed against the ...
Source: Roche Investor Update - September 18, 2020 Category: Pharmaceuticals Source Type: news

Progress toward antiviral treatments for COVID-19
COVID-19 is caused by a virus known as SARS-CoV-2, which is similar in structure to two other viruses that have caused recent outbreaks: SARS-CoV, which caused an outbreak of SARS in 2003, and MERS-CoV, the cause of a 2012 outbreak of Middle East Respiratory Syndrome. (Source: World Pharma News)
Source: World Pharma News - September 15, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Progress toward antiviral treatments for COVID-19
(American Institute of Physics) COVID-19 is caused by the virus SARS-CoV-2, which is structurally similar to the viruses that cause SARS-CoV and MERS-CoV. In The Journal of Chemical Physics, scientists report molecular-level investigations of these viruses, providing a possible pathway to antiviral drugs to fight the diseases. They looked at a viral protein that plays a role in the virus's ability to replicate and in defeating the host's immune system, making it an attractive target for potential drug treatments. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 15, 2020 Category: Infectious Diseases Source Type: news

Cochrane Rapid Review examines travel-related control measures to contain the COVID-19 pandemic
 Can travel-related control measures contain the spread of the COVID-19 pandemic?What are travel-related control measures?To contain the spread of COVID-19, numerous countries have implemented control measures related to international travel. These include:complete closure of borders (i.e. a total ban on any border crossings);partial travel restrictions (e.g. restrictions on air travel only, or restrictions on travellers from certain countries);entry or exit screening (e.g. when travellers are asked about symptoms, examined physically, or tested for infection when leaving or entering a country);quarantine of traveller...
Source: Cochrane News and Events - September 10, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems
Basel, 04 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® SARS-CoV-2& Influenza A/B Test for use on the cobas ® 6800/8800 Systems has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19. Additionally, it is available in markets accepting the CE mark.“With the approaching flu season, this new...
Source: Roche Media News - September 4, 2020 Category: Pharmaceuticals Source Type: news

Roche receives FDA Emergency Use Authorization for the cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas 6800/8800 Systems
Basel, 04 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas ® SARS-CoV-2& Influenza A/B Test for use on the cobas ® 6800/8800 Systems has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19. Additionally, it is available in markets accepting the CE mark.“With the approaching flu season, this new...
Source: Roche Investor Update - September 4, 2020 Category: Pharmaceuticals Source Type: news

Plasmin could be the link between COVID-19 comorbidities and serious illness
(University of Alabama at Birmingham) Why is the COVID-19 virus more dangerous in people with comorbidities? Literature analysis shows that comorbidities like hypertension, diabetes, coronary heart disease, cerebrovascular illness, chronic obstructive pulmonary disease and kidney dysfunction all feature elevated levels of the extracellular protease plasmin. Plasmin is able to nick proteins sequences called furin sites. For many viruses, this nicking increases viral infectivity, including SARS and MERS -- the two virulent coronaviruses that are related to the COVID-19 virus. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 2, 2020 Category: Infectious Diseases Source Type: news

High rates of delirium, persistent fatigue and post-traumatic stress disorder were common after severe infection in previous coronavirus outbreaks, NIHR
Little is known about the mental health consequences of severe COVID-19 illness because it is caused by a new coronavirus. Previous outbreaks caused by other coronaviruses (severe acute respiratory syndrome, SARS, and Middle East respiratory syndrome, MERS) may provide insights into ongoing problems after recovery from severe illness. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 28, 2020 Category: Consumer Health News Source Type: news

How Convalescent Plasma Could Help Fight COVID-19
The last time most of us gave any thought to antibodies was probably in high school biology, but we’re getting a crash refresher course thanks to COVID-19. They are, after all, the key to our best defenses against SARS-CoV-2, the virus that’s caused the global pandemic. People who have been infected likely rely on antibodies to recover, and antibodies are what vaccines are designed to produce. Or at least that’s what infectious-disease and public-health experts assume for now. Because SARS-CoV-2 is such a new virus, even the world’s best authorities aren’t yet sure what it will take to build p...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Leading in Time of COVID: A True Test of Leadership
By Folake OlayinkaAug 15 2020 (IPS) In 1918, the Spanish Flu, a deadly influenza caused by the H1N1 virus, decimated the world. Over the course of four successive waves, it infected 500 million people, about a third of the world’s population at the time, resulting in 50 million deaths. More recently between 2014 and mid-2016 , the Ebola virus epidemic was the most widespread outbreak of Ebola virus disease in history—causing devastating  loss of life and socioeconomic disruption in the West Africa region, mainly in Guinea, Liberia and Sierra Leone. These outbreaks, as well as SARS and MERS, each have ...
Source: IPS Inter Press Service - Health - August 15, 2020 Category: International Medicine & Public Health Authors: Folake Olayinka Tags: Democracy Headlines Health Source Type: news

High rates of delirium, persistent fatigue and post-traumatic stress disorder were common after severe infection in previous coronavirus outbreaks, NIHR
Little is known about the mental health consequences of severe COVID-19 illness because it is caused by a new coronavirus. Previous outbreaks caused by other coronaviruses (severe acute respiratory syndrome, SARS, and Middle East respiratory syndrome, MERS) may provide insights into ongoing problems after recovery from severe illness. Researchers looked at reports of psychiatric problems during SARS and MERS outbreaks and compared this to early data from the COVID-19 pandemic. Delirium (sudden confusion) was common while patients were in hospital with any of the coronavirus infections (SARS, MERS or COVID-19). Later, once ...
Source: Current Awareness Service for Health (CASH) - August 13, 2020 Category: Consumer Health News Source Type: news

Africa: The One Health Approach to Preventing the Next Pandemic
[AfricaFocus] Editor's Note: "COVID-19 is just one example of the rising trend of diseases - from Ebola to MERS to West Nile and Rift Valley fevers - caused by viruses that have jumped from animal hosts into the human population. ... The rising trend in zoonotic diseases is driven by the degradation of our natural environment - through land degradation, wildlife exploitation, resource extraction, climate change, and other stresses." - Press release from UN Environment Programme (UNEP) and International Livestock Re (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 3, 2020 Category: African Health Source Type: news

Broad antivirals kill SARS-CoV-2, the MERS virus, and other coronaviruses in cells and mice
(American Association for the Advancement of Science) A team of scientists has engineered antiviral compounds that can kill several types of coronaviruses, including SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 3, 2020 Category: Infectious Diseases Source Type: news

Bill Gates on How the U.S. Can Course Correct Its COVID-19 Response: ‘You Wish Experts Were Taking Charge’
The U.S. domestic response to the COVID-19 pandemic thus far has been “weak,” Bill Gates believes. The Bill and Melinda Gates Foundation co-chair and Microsoft co-founder told TIME senior health correspondent Alice Park during a TIME100 Talks discussion on Thursday that he’d give the U.S.’s COVID-19 response, “on a relative and absolute basis, not a passing grade.” But, he added, the U.S.’s funding for vaccine and therapeutic research “has been the best in the world,” so if it coordinates to share resources globally, the U.S. could “potentially score the highest&...
Source: TIME: Health - July 30, 2020 Category: Consumer Health News Authors: Madeleine Carlisle Tags: Uncategorized COVID-19 News Desk TIME100 Talks Source Type: news

Inside the Global Quest to Trace the Origins of COVID-19 —and Predict Where It Will Go Next
It wasn’t greed, or curiosity, that made Li Rusheng grab his shotgun and enter Shitou Cave. It was about survival. During Mao-era collectivization of the early 1970s, food was so scarce in the emerald valleys of southwestern China’s Yunnan province that farmers like Li could expect to eat meat only once a year–if they were lucky. So, craving protein, Li and his friends would sneak into the cave to hunt the creatures they could hear squeaking and fluttering inside: bats. Li would creep into the gloom and fire blindly at the vaulted ceiling, picking up any quarry that fell to the ground, while his companion...
Source: TIME: Health - July 23, 2020 Category: Consumer Health News Authors: Charlie Campbell/ Yuxi, Yunnan and Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Early COVID-19 Vaccine Results Look ‘Really Encouraging,’ Says NIH Boss Dr. Francis Collins
This article is part of #TIME100Talks: Finding Hope, a special series featuring leaders across different fields encouraging action toward a better world. Want more? Sign up for access to more virtual events, including live conversations with influential newsmakers. (Source: TIME: Health)
Source: TIME: Health - July 17, 2020 Category: Consumer Health News Authors: Chris Wilson Tags: Uncategorized COVID-19 TIME100 Talks Source Type: news

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia
Between 1 April and 31 May 2020, the National IHR Focal Point of Saudi Arabia reported nine new cases of MERS-CoV infection, including five deaths. The cases were reported from Riyadh (seven cases), Assir (one case) and Northern (one case) Regions. Most cases were and ages of the reported cases ranged from 40 to 96 years. Of the cases reported in Riyadh six were from a hospital outbreak in the region between 21 and 31 May 2020: an index case who was a newly admitted patient, and five secondary cases identified through contact tracing. One of the secondary cases was a health care worker and the other four were in-patients a...
Source: WHO Disease Outbreaks - July 2, 2020 Category: Infectious Diseases Tags: news Source Type: news

Covid-19 and the HIV connection revealed
(Natural News) Coronaviruses are pervasive throughout the human population and their symptoms typically manifest as the common cold. The four most popular coronaviruses identified include 229E (alpha coronavirus), NL63 (alpha coronavirus), OC43 (beta coronavirus), and HKU1 (beta coronavirus). More potent coronaviruses have emerged in recent years. MERS-CoV I is a beta coronavirus that causes Middle... (Source: NaturalNews.com)
Source: NaturalNews.com - June 29, 2020 Category: Consumer Health News Source Type: news

Up to 30% of Covid-19 survivors could be left with damaged and scarred lungs
Leaked NHS guidance says up to 30 per cent of Covid-19 survivors may suffer long-term lung damage, if it takes the same path as other coronaviruses such as SARS or MERS. (Source: the Mail online | Health)
Source: the Mail online | Health - June 23, 2020 Category: Consumer Health News Source Type: news

The Lancet Infectious Diseases: Study from Chinese city of Guangzhou provides key insights on how COVID-19 spreads in households
(The Lancet) New modelling research, published in The Lancet Infectious Diseases journal, suggests the coronavirus (SARS-CoV-2) that causes COVID-19 may spread more easily among people living together and family members than severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS). The estimates are the first of their kind to quantify symptomless transmission. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 17, 2020 Category: International Medicine & Public Health Source Type: news

The U.S. Government's Push For Coronavirus Vaccine 'Warp Speed' Faces Potential Black Hole Of Red Tape And Universe Of Unknowns
Dr. Stephen Thomas, who helped develop vaccine candidates for diseases such as Ebola, Zika and MERS, discusses the challenges involved in accelerating development during a pandemic. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 16, 2020 Category: Pharmaceuticals Authors: Stephen Thomas, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Business /business Policy /policy Editors' Pick editors-pick Decision Maker decision-maker Coronavirus Source Type: news

Pharmacologic Treatments and Supportive Care for MERS Pharmacologic Treatments and Supportive Care for MERS
What pharmacologic and supportive therapies are available for MERS and how effective are they?Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2020 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

MERS Fast Facts
Check out CNN's MERS Fast Facts to learn more about Middle East Respiratory Syndrome, a viral respiratory illness first identified in Saudi Arabia in 2012. (Source: CNN.com - Health)
Source: CNN.com - Health - June 6, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Outbreak exercise showed ‘clear gap’ in readiness
A 2018 MERS outbreak exercise in Scotland revealed concerns over protective gear, the BBC learns. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 5, 2020 Category: Consumer Health News Source Type: news

Wearing Face Masks and Social Distancing Actually Work to Contain COVID-19, According to a New Study
The best practices for controlling an infectious disease like COVID-19 aren’t easy to follow—keeping six feet apart from others, wearing face masks in public, and, if you’re a health care worker, wearing shields to protect your eyes as well. But in a study published Monday in The Lancet, researchers provide the strongest evidence yet that these practices do indeed lower the risk of spreading the virus. An international group of scientists, led by senior author Dr. Holger Schunemann, professor of clinical epidemiology and medicine at McMaster University in Ontario, Canada, analyzed 172 studies conducted in...
Source: TIME: Health - June 1, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news